The effect of etanercept on Graves' ophthalmopathy: a pilot study
The effect of etanercept on Graves' ophthalmopathy: a pilot study
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Purpose
To assess the effect of etanercept, an antitumour necrosis factor (anti-TNF) drug, on clinical signs in Graves' ophthalmopathy (GO).
Methods
A total of 10 consecutive patients (seven female, three male) with recent-onset, active, mildly-to-moderately severe GO were treated with subcutaneous injections of 25 mg etanercept (Enbrel
Alternative Titles
Full title
The effect of etanercept on Graves' ophthalmopathy: a pilot study
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_218391704
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_218391704
Other Identifiers
ISSN
0950-222X
E-ISSN
1476-5454
DOI
10.1038/sj.eye.6701768
